A healthcare artificial intelligence company that spun out of New York City-based Mount Sinai Health System has raised $20.7 million in a series B funding round.
PreciseDx is a New York-based AI platform that provides solutions such as cancer risk stratification and personalized treatment analytics for the healthcare industry.